AddLife AB (publ) (ALIF-B.ST) fair value

ACCE thesis

AddLife is a Swedish group that supplies consumables, sample preparation instruments and laboratory equipment for life science and clinical customers, serving much of its business through its own distribution arms and niche brands. It operates as a roll-up with a long record of acquisitions, and its edge rests on sticky, recurring consumables sold into research labs and hospitals that rarely switch suppliers. Revenue is growing 5.5% and gross margin sits at 38.4%, but operating margin of 8.7% leaves little room for error and says the integration and overhead costs of the acquisition model are still heavy. The stock trades on 34.3x trailing and 56.8x forward earnings, so the market is pricing in a meaningful margin recovery that the reported numbers do not yet show. With an ROE of 10.9% and no index membership, the case depends on whether operating leverage from recent acquisitions can lift margins toward a level that justifies the multiple, which is worth testing against the latest order book and organic growth disclosures.